The Effects of Cytokines on Spontaneous Hepatitis B Surface Antigen Seroconversion in Chronic Hepatitis B Virus Infection
We examined the role of human cytokines in the natural course of hepatitis B surface Ag (HBsAg) seroconversion in chronic hepatitis B virus (HBV) infection. The clinical course of spontaneous HBsAg seroconversion was assessed in 296 chronically HBV-infected patients. Single nucleotide polymorphisms...
Saved in:
Published in | The Journal of immunology (1950) Vol. 194; no. 2; pp. 690 - 696 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
15.01.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | We examined the role of human cytokines in the natural course of hepatitis B surface Ag (HBsAg) seroconversion in chronic hepatitis B virus (HBV) infection. The clinical course of spontaneous HBsAg seroconversion was assessed in 296 chronically HBV-infected patients. Single nucleotide polymorphisms (SNPs) in IL-1β, IL-2, IL-4, IL-10, IL-12β, IL-13, IL-27, and IFN-γ genes were examined in 296 chronically HBV-infected patients and another 193 HBV recoverers. The HBsAg a determinant sequence of chronically HBV-infected subjects with and without HBsAg seroconversion was also analyzed. The start of the immune-clearance phase (serum alanine aminotransferase levels > 30 IU/l) before the age of 48 mo and hepatitis B e Ag (HBeAg) seroconversion before the age of 10 y predicted spontaneous HBsAg seroconversion in chronically HBV-infected patients (odds ratios 17.7 and 5.0; p < 0.001 and p < 0.002, respectively). The A-allele of IL-10 SNP rs1800872 was associated with higher IL-10 serum levels, and the G-allele of IL-12β SNP rs3212217 was associated with sustained high serum IL-12p70 levels during the immune-clearance phase. Both were predictors of spontaneous HBsAg seroconversion and HBV recovery (odds ratios 4.0 and 26.3; p = 0.002 and p < 0.001, respectively). Spontaneous HBsAg seroconversion was not related to sex, HBV genotype, or HBsAg a determinant mutation. The start of immune-clearance phase, age at HBeAg seroconversion, and serum IL-10 and IL-12 levels are associated with the course of the immune-clearance phase in chronic HBV infection, and are predictive of spontaneous HBsAg seroconversion and HBV recovery. |
---|---|
AbstractList | We examined the role of human cytokines in the natural course of hepatitis B surface Ag (HBsAg) seroconversion in chronic hepatitis B virus (HBV) infection. The clinical course of spontaneous HBsAg seroconversion was assessed in 296 chronically HBV-infected patients. Single nucleotide polymorphisms (SNPs) in IL-1β, IL-2, IL-4, IL-10, IL-12β, IL-13, IL-27, and IFN-γ genes were examined in 296 chronically HBV-infected patients and another 193 HBV recoverers. The HBsAg a determinant sequence of chronically HBV-infected subjects with and without HBsAg seroconversion was also analyzed. The start of the immune-clearance phase (serum alanine aminotransferase levels > 30 IU/l) before the age of 48 mo and hepatitis B e Ag (HBeAg) seroconversion before the age of 10 y predicted spontaneous HBsAg seroconversion in chronically HBV-infected patients (odds ratios 17.7 and 5.0; p < 0.001 and p < 0.002, respectively). The A-allele of IL-10 SNP rs1800872 was associated with higher IL-10 serum levels, and the G-allele of IL-12β SNP rs3212217 was associated with sustained high serum IL-12p70 levels during the immune-clearance phase. Both were predictors of spontaneous HBsAg seroconversion and HBV recovery (odds ratios 4.0 and 26.3; p = 0.002 and p < 0.001, respectively). Spontaneous HBsAg seroconversion was not related to sex, HBV genotype, or HBsAg a determinant mutation. The start of immune-clearance phase, age at HBeAg seroconversion, and serum IL-10 and IL-12 levels are associated with the course of the immune-clearance phase in chronic HBV infection, and are predictive of spontaneous HBsAg seroconversion and HBV recovery.We examined the role of human cytokines in the natural course of hepatitis B surface Ag (HBsAg) seroconversion in chronic hepatitis B virus (HBV) infection. The clinical course of spontaneous HBsAg seroconversion was assessed in 296 chronically HBV-infected patients. Single nucleotide polymorphisms (SNPs) in IL-1β, IL-2, IL-4, IL-10, IL-12β, IL-13, IL-27, and IFN-γ genes were examined in 296 chronically HBV-infected patients and another 193 HBV recoverers. The HBsAg a determinant sequence of chronically HBV-infected subjects with and without HBsAg seroconversion was also analyzed. The start of the immune-clearance phase (serum alanine aminotransferase levels > 30 IU/l) before the age of 48 mo and hepatitis B e Ag (HBeAg) seroconversion before the age of 10 y predicted spontaneous HBsAg seroconversion in chronically HBV-infected patients (odds ratios 17.7 and 5.0; p < 0.001 and p < 0.002, respectively). The A-allele of IL-10 SNP rs1800872 was associated with higher IL-10 serum levels, and the G-allele of IL-12β SNP rs3212217 was associated with sustained high serum IL-12p70 levels during the immune-clearance phase. Both were predictors of spontaneous HBsAg seroconversion and HBV recovery (odds ratios 4.0 and 26.3; p = 0.002 and p < 0.001, respectively). Spontaneous HBsAg seroconversion was not related to sex, HBV genotype, or HBsAg a determinant mutation. The start of immune-clearance phase, age at HBeAg seroconversion, and serum IL-10 and IL-12 levels are associated with the course of the immune-clearance phase in chronic HBV infection, and are predictive of spontaneous HBsAg seroconversion and HBV recovery. We examined the role of human cytokines in the natural course of hepatitis B surface Ag (HBsAg) seroconversion in chronic hepatitis B virus (HBV) infection. The clinical course of spontaneous HBsAg seroconversion was assessed in 296 chronically HBV-infected patients. Single nucleotide polymorphisms (SNPs) in IL-1 beta , IL-2, IL-4, IL-10, IL-12 beta , IL-13, IL-27, and IFN- gamma genes were examined in 296 chronically HBV-infected patients and another 193 HBV recoverers. The HBsAg a determinant sequence of chronically HBV-infected subjects with and without HBsAg seroconversion was also analyzed. The start of the immune-clearance phase (serum alanine aminotransferase levels > 30 IU/l) before the age of 48 mo and hepatitis B e Ag (HBeAg) seroconversion before the age of 10 y predicted spontaneous HBsAg seroconversion in chronically HBV-infected patients (odds ratios 17.7 and 5.0; p < 0.001 and p < 0.002, respectively). The A-allele of IL-10 SNP rs1800872 was associated with higher IL-10 serum levels, and the G-allele of IL-12 beta SNP rs3212217 was associated with sustained high serum IL-12p70 levels during the immune-clearance phase. Both were predictors of spontaneous HBsAg seroconversion and HBV recovery (odds ratios 4.0 and 26.3; p = 0.002 and p < 0.001, respectively). Spontaneous HBsAg seroconversion was not related to sex, HBV genotype, or HBsAg a determinant mutation. The start of immune-clearance phase, age at HBeAg seroconversion, and serum IL-10 and IL-12 levels are associated with the course of the immune-clearance phase in chronic HBV infection, and are predictive of spontaneous HBsAg seroconversion and HBV recovery. We examined the role of human cytokines in the natural course of hepatitis B surface Ag (HBsAg) seroconversion in chronic hepatitis B virus (HBV) infection. The clinical course of spontaneous HBsAg seroconversion was assessed in 296 chronically HBV-infected patients. Single nucleotide polymorphisms (SNPs) in IL-1β, IL-2, IL-4, IL-10, IL-12β, IL-13, IL-27, and IFN-γ genes were examined in 296 chronically HBV-infected patients and another 193 HBV recoverers. The HBsAg a determinant sequence of chronically HBV-infected subjects with and without HBsAg seroconversion was also analyzed. The start of the immune-clearance phase (serum alanine aminotransferase levels > 30 IU/l) before the age of 48 mo and hepatitis B e Ag (HBeAg) seroconversion before the age of 10 y predicted spontaneous HBsAg seroconversion in chronically HBV-infected patients (odds ratios 17.7 and 5.0; p < 0.001 and p < 0.002, respectively). The A-allele of IL-10 SNP rs1800872 was associated with higher IL-10 serum levels, and the G-allele of IL-12β SNP rs3212217 was associated with sustained high serum IL-12p70 levels during the immune-clearance phase. Both were predictors of spontaneous HBsAg seroconversion and HBV recovery (odds ratios 4.0 and 26.3; p = 0.002 and p < 0.001, respectively). Spontaneous HBsAg seroconversion was not related to sex, HBV genotype, or HBsAg a determinant mutation. The start of immune-clearance phase, age at HBeAg seroconversion, and serum IL-10 and IL-12 levels are associated with the course of the immune-clearance phase in chronic HBV infection, and are predictive of spontaneous HBsAg seroconversion and HBV recovery. |
Author | Chen, Huey-Ling Hsu, Hong-Yuan Chiu, Yu-Chun Chang, Mei-Hwei Wu, Jia-Feng Ni, Yen-Hsuan |
Author_xml | – sequence: 1 givenname: Jia-Feng surname: Wu fullname: Wu, Jia-Feng – sequence: 2 givenname: Hong-Yuan surname: Hsu fullname: Hsu, Hong-Yuan – sequence: 3 givenname: Yu-Chun surname: Chiu fullname: Chiu, Yu-Chun – sequence: 4 givenname: Huey-Ling surname: Chen fullname: Chen, Huey-Ling – sequence: 5 givenname: Yen-Hsuan surname: Ni fullname: Ni, Yen-Hsuan – sequence: 6 givenname: Mei-Hwei surname: Chang fullname: Chang, Mei-Hwei |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25505294$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc9PHCEYhomx0dX23pPh6GUsMMAwR934KzHpQdsrmWE-KjoDKzAm-9_LZncPNWl6-kLyPO-Xj_cEHfrgAaHvlFxwwtsfL26aZh_GC8oJlaI9QAsqBKmkJPIQLQhhrKKNbI7RSUovhBBJGD9Cx6xAgrV8gdZPz4CvrQWTEw4WL9c5vDoP5eHx4yr43HkIc8J3sOqyyy7hK_w4R9sZwJc-uz9QOIjBBP8OMbmiOY-XzzF4Z_6yfrtYcu79ZlfBvqIvthsTfNvNU_Tr5vppeVc9_Ly9X14-VKauWa5sPQzUDKxnHWdUUd4zYnrDFe-FMYwOjbFcQc15C0pYJmoxiMZSpRQwDrI-Refb3FUMbzOkrCeXDIzj9jBNFVGybpu2-T8qOZOkaQUr6NkOnfsJBr2KburiWu9_tgByC5gYUopgtXG52xyeY-dGTYneVKj3FepdhUUkn8R99j-VD5Xroas |
CitedBy_id | crossref_primary_10_1055_a_2153_8836 crossref_primary_10_2147_JIR_S411492 crossref_primary_10_1186_s12929_015_0199_y crossref_primary_10_4254_wjh_v7_i30_2980 crossref_primary_10_1016_j_jhepr_2024_101061 crossref_primary_10_1093_infdis_jiy048 crossref_primary_10_3389_fmolb_2021_805625 crossref_primary_10_1016_j_cgh_2022_02_046 crossref_primary_10_1002_hep_28222 crossref_primary_10_1002_iid3_70017 crossref_primary_10_1038_srep37015 crossref_primary_10_3389_fimmu_2022_1104329 crossref_primary_10_1002_jmv_24518 crossref_primary_10_1007_s00535_021_01840_w crossref_primary_10_1186_s12879_019_3853_2 crossref_primary_10_1002_jmv_24572 crossref_primary_10_12677_ACM_2023_13112604 crossref_primary_10_1111_hepr_12726 crossref_primary_10_1186_s40001_016_0218_9 crossref_primary_10_1016_j_cgh_2024_07_036 crossref_primary_10_1097_MD_0000000000001435 crossref_primary_10_1016_j_intimp_2022_108982 crossref_primary_10_1155_2019_6915850 crossref_primary_10_1038_s41598_023_50216_y |
Cites_doi | 10.1097/01.LAB.0000087589.37269.FC 10.1093/infdis/jir852 10.1016/j.jhep.2004.06.031 10.1128/jvi.71.1.345-353.1997 10.1002/hep.20888 10.1002/hep.23983 10.1371/journal.pone.0053008 10.1203/01.PDR.0000130480.51066.FB 10.1371/journal.ppat.1003208 10.1128/JVI.77.23.12875-12880.2003 10.1111/j.1440-1746.2007.04846.x 10.1056/NEJM199504203321604 10.1111/j.1478-3231.2010.02340.x 10.1016/S0168-8278(00)80078-1 10.1002/hep.21077 10.1053/j.gastro.2011.04.046 10.1128/jvi.74.10.4729-4737.2000 10.1016/S1470-2045(13)70350-4 10.1111/j.1572-0241.2002.05926.x 10.1086/341508 10.1097/MPG.0b013e31822a033e 10.1053/j.gastro.2009.09.018 10.1016/j.ajpath.2012.03.036 10.1016/j.jhep.2008.09.017 10.1093/cid/cir755 10.1371/journal.pone.0039175 10.1111/j.1478-3231.2011.02481.x 10.1016/S0140-6736(81)90585-7 10.3851/IMP1497 10.1002/hep.1840150304 10.1002/hep.510260336 10.4049/jimmunol.177.12.8633 |
ContentType | Journal Article |
Copyright | Copyright © 2015 by The American Association of Immunologists, Inc. |
Copyright_xml | – notice: Copyright © 2015 by The American Association of Immunologists, Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 7U7 7U9 C1K H94 |
DOI | 10.4049/jimmunol.1401659 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts Toxicology Abstracts Virology and AIDS Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts Virology and AIDS Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1550-6606 |
EndPage | 696 |
ExternalDocumentID | 25505294 10_4049_jimmunol_1401659 |
Genre | Clinical Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -~X .55 0R~ 18M 2WC 34G 39C 53G 5GY 5RE 5VS 5WD 79B 85S AARDX AAYXX ABCQX ABDFA ABEJV ABGNP ABJNI ABOCM ABPPZ ABXVV ACGFO ACGFS ACIWK ACNCT ACPRK ADBBV ADIPN ADNWM AENEX AETEA AFHIN AFOSN AFRAH AGORE AHMMS AHWXS AIZAD ALMA_UNASSIGNED_HOLDINGS ARBBW BAWUL BCRHZ BTFSW CITATION D0L DIK DU5 E3Z EBS EJD F5P GX1 IH2 K-O KOP KQ8 L7B OCZFY OK1 OWPYF P0W P2P PQQKQ R.V RHI ROX RZQ SJN TR2 TWZ W8F WH7 WOQ X7M XJT XSW XTH YHG CGR CUY CVF ECM EIF NPM 7X8 FRP 7T5 7U7 7U9 C1K H94 |
ID | FETCH-LOGICAL-c332t-f3dd1cd2b2a421814b20cbc484b5cc21d7cf48e3449e85f2535d57f1888e24e63 |
ISSN | 0022-1767 1550-6606 |
IngestDate | Tue Aug 05 10:33:16 EDT 2025 Fri Jul 11 15:42:07 EDT 2025 Mon Jul 21 06:03:40 EDT 2025 Tue Aug 05 12:14:30 EDT 2025 Thu Apr 24 23:01:48 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | https://academic.oup.com/pages/standard-publication-reuse-rights Copyright © 2015 by The American Association of Immunologists, Inc. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c332t-f3dd1cd2b2a421814b20cbc484b5cc21d7cf48e3449e85f2535d57f1888e24e63 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 25505294 |
PQID | 1642607952 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1808639797 proquest_miscellaneous_1642607952 pubmed_primary_25505294 crossref_citationtrail_10_4049_jimmunol_1401659 crossref_primary_10_4049_jimmunol_1401659 |
PublicationCentury | 2000 |
PublicationDate | 2015-01-15 2015-Jan-15 20150115 |
PublicationDateYYYYMMDD | 2015-01-15 |
PublicationDate_xml | – month: 01 year: 2015 text: 2015-01-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of immunology (1950) |
PublicationTitleAlternate | J Immunol |
PublicationYear | 2015 |
References | Yeh (2025030704313093800_r17) 2004; 41 Wu (2025030704313093800_r12) 2012; 54 Mack (2025030704313093800_r26) 2004; 56 Su (2025030704313093800_r19) 2012; 205 Schurich (2025030704313093800_r27) 2013; 9 Cheng (2025030704313093800_r10) 2013; 8 Mu (2025030704313093800_r20) 2009; 50 Lin (2025030704313093800_r22) 1989; 9 Lertkhachonsuk (2025030704313093800_r2) 2013; 14 Wu (2025030704313093800_r15) 2010; 138 Hsu (2025030704313093800_r4) 1992; 15 Kao (2025030704313093800_r13) 2010; 30 Takakura (2025030704313093800_r14) 2007; 22 Tseng (2025030704313093800_r5) 2011; 141 Bortolotti (2025030704313093800_r7) 2006; 43 Nishida (2025030704313093800_r9) 2012; 7 Miyazoe (2025030704313093800_r24) 2002; 97 Jin (2025030704313093800_r34) 2011; 53 Lainé (2025030704313093800_r31) 2003; 77 Bozkaya (2025030704313093800_r23) 2000; 47 Ethuin (2025030704313093800_r28) 2003; 83 Rigopoulou (2025030704313093800_r29) 2005; 42 Marx (2025030704313093800_r6) 2002; 186 Hsu (2025030704313093800_r18) 1997; 26 Cameron (2025030704313093800_r33) 2006; 177 Beasley (2025030704313093800_r1) 1981; 2 Thursz (2025030704313093800_r8) 1995; 332 Chu (2025030704313093800_r3) 2010; 15 Carreño (2025030704313093800_r30) 2000; 32 Scaglioni (2025030704313093800_r32) 1997; 71 Shi (2025030704313093800_r21) 2012; 32 Santin (2025030704313093800_r25) 2000; 74 Wu (2025030704313093800_r16) 2012; 181 Chu (2025030704313093800_r11) 2012; 54 |
References_xml | – volume: 83 start-page: 1353 year: 2003 ident: 2025030704313093800_r28 article-title: Regulation of interleukin 12 p40 and p70 production by blood and alveolar phagocytes during severe sepsis publication-title: Lab. Invest. doi: 10.1097/01.LAB.0000087589.37269.FC – volume: 205 start-page: 757 year: 2012 ident: 2025030704313093800_r19 article-title: Effect of age on the incidence of acute hepatitis B after 25 years of a universal newborn hepatitis B immunization program in Taiwan publication-title: J. Infect. Dis. doi: 10.1093/infdis/jir852 – volume: 41 start-page: 659 year: 2004 ident: 2025030704313093800_r17 article-title: Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis publication-title: J. Hepatol. doi: 10.1016/j.jhep.2004.06.031 – volume: 71 start-page: 345 year: 1997 ident: 2025030704313093800_r32 article-title: Posttranscriptional regulation of hepatitis B virus replication by the precore protein publication-title: J. Virol. doi: 10.1128/jvi.71.1.345-353.1997 – volume: 42 start-page: 1028 year: 2005 ident: 2025030704313093800_r29 article-title: Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity publication-title: Hepatology doi: 10.1002/hep.20888 – volume: 53 start-page: 219 year: 2011 ident: 2025030704313093800_r34 article-title: Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells publication-title: Hepatology doi: 10.1002/hep.23983 – volume: 8 start-page: e53008 year: 2013 ident: 2025030704313093800_r10 article-title: Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients publication-title: PLoS ONE doi: 10.1371/journal.pone.0053008 – volume: 56 start-page: 79 year: 2004 ident: 2025030704313093800_r26 article-title: Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation publication-title: Pediatr. Res. doi: 10.1203/01.PDR.0000130480.51066.FB – volume: 9 start-page: e1003208 year: 2013 ident: 2025030704313093800_r27 article-title: The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1003208 – volume: 77 start-page: 12875 year: 2003 ident: 2025030704313093800_r31 article-title: In vitro and in vivo interactions between the hepatitis B virus protein P22 and the cellular protein gC1qR publication-title: J. Virol. doi: 10.1128/JVI.77.23.12875-12880.2003 – volume: 22 start-page: 1271 year: 2007 ident: 2025030704313093800_r14 article-title: Possible involvement of cytokine gene polymorphisms in fulminant hepatitis publication-title: J. Gastroenterol. Hepatol. doi: 10.1111/j.1440-1746.2007.04846.x – volume: 332 start-page: 1065 year: 1995 ident: 2025030704313093800_r8 article-title: Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199504203321604 – volume: 9 start-page: 737 year: 1989 ident: 2025030704313093800_r22 article-title: Hepatitis B virus markers in Chinese twins publication-title: Anticancer Res. – volume: 30 start-page: 1448 year: 2010 ident: 2025030704313093800_r13 article-title: Tumour necrosis factor-α promoter region polymorphisms affect the course of spontaneous HBsAg clearance publication-title: Liver Int. doi: 10.1111/j.1478-3231.2010.02340.x – volume: 32 start-page: 317 year: 2000 ident: 2025030704313093800_r30 article-title: A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B publication-title: J. Hepatol. doi: 10.1016/S0168-8278(00)80078-1 – volume: 43 start-page: 556 year: 2006 ident: 2025030704313093800_r7 article-title: Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study publication-title: Hepatology doi: 10.1002/hep.21077 – volume: 141 start-page: 517 year: 2011 ident: 2025030704313093800_r5 article-title: Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters publication-title: Gastroenterology doi: 10.1053/j.gastro.2011.04.046 – volume: 74 start-page: 4729 year: 2000 ident: 2025030704313093800_r25 article-title: Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes publication-title: J. Virol. doi: 10.1128/jvi.74.10.4729-4737.2000 – volume: 14 start-page: e497 year: 2013 ident: 2025030704313093800_r2 article-title: Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013 publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(13)70350-4 – volume: 47 start-page: 1675 year: 2000 ident: 2025030704313093800_r23 article-title: Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease publication-title: Hepatogastroenterology – volume: 97 start-page: 2086 year: 2002 ident: 2025030704313093800_r24 article-title: Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus publication-title: Am. J. Gastroenterol. doi: 10.1111/j.1572-0241.2002.05926.x – volume: 186 start-page: 295 year: 2002 ident: 2025030704313093800_r6 article-title: Long-term follow-up of chronic hepatitis B virus infection in children of different ethnic origins publication-title: J. Infect. Dis. doi: 10.1086/341508 – volume: 54 start-page: 97 year: 2012 ident: 2025030704313093800_r12 article-title: Predictive effect of serial serum alanine aminotransferase levels on spontaneous HBeAg seroconversion in chronic genotype B and C HBV-infected children publication-title: J. Pediatr. Gastroenterol. Nutr. doi: 10.1097/MPG.0b013e31822a033e – volume: 138 start-page: 165 year: 2010 ident: 2025030704313093800_r15 article-title: Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion publication-title: Gastroenterology doi: 10.1053/j.gastro.2009.09.018 – volume: 181 start-page: 19 year: 2012 ident: 2025030704313093800_r16 article-title: Suppression of furin by interferon-γ and the impact on hepatitis B virus antigen biosynthesis in human hepatocytes publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2012.03.036 – volume: 50 start-page: 264 year: 2009 ident: 2025030704313093800_r20 article-title: Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan publication-title: J. Hepatol. doi: 10.1016/j.jhep.2008.09.017 – volume: 54 start-page: 88 year: 2012 ident: 2025030704313093800_r11 article-title: Prevalence of and risk factors for hepatitis B viremia after spontaneous hepatitis B surface antigen seroclearance in hepatitis B carriers publication-title: Clin. Infect. Dis. doi: 10.1093/cid/cir755 – volume: 7 start-page: e39175 year: 2012 ident: 2025030704313093800_r9 article-title: Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean publication-title: PLoS ONE doi: 10.1371/journal.pone.0039175 – volume: 32 start-page: 231 year: 2012 ident: 2025030704313093800_r21 article-title: Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis publication-title: Liver Int. doi: 10.1111/j.1478-3231.2011.02481.x – volume: 2 start-page: 1129 year: 1981 ident: 2025030704313093800_r1 article-title: Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan publication-title: Lancet doi: 10.1016/S0140-6736(81)90585-7 – volume: 15 start-page: 133 year: 2010 ident: 2025030704313093800_r3 article-title: Hepatitis B surface antigen seroclearance during chronic HBV infection publication-title: Antivir. Ther. (Lond.) doi: 10.3851/IMP1497 – volume: 15 start-page: 382 year: 1992 ident: 2025030704313093800_r4 article-title: Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection publication-title: Hepatology doi: 10.1002/hep.1840150304 – volume: 26 start-page: 786 year: 1997 ident: 2025030704313093800_r18 article-title: Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis publication-title: Hepatology doi: 10.1002/hep.510260336 – volume: 177 start-page: 8633 year: 2006 ident: 2025030704313093800_r33 article-title: Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C>T, a polymorphism associated with allergic inflammation publication-title: J. Immunol. doi: 10.4049/jimmunol.177.12.8633 |
SSID | ssj0006024 |
Score | 2.2895384 |
Snippet | We examined the role of human cytokines in the natural course of hepatitis B surface Ag (HBsAg) seroconversion in chronic hepatitis B virus (HBV) infection.... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 690 |
SubjectTerms | Adult Cross-Sectional Studies Cytokines - genetics Cytokines - immunology Female Follow-Up Studies Hepatitis B e Antigens - genetics Hepatitis B e Antigens - immunology Hepatitis B virus Hepatitis B virus - genetics Hepatitis B virus - immunology Hepatitis B, Chronic - genetics Hepatitis B, Chronic - immunology Hepatitis B, Chronic - pathology Humans Immunity, Cellular - genetics Male Middle Aged Mutation Polymorphism, Single Nucleotide Retrospective Studies |
Title | The Effects of Cytokines on Spontaneous Hepatitis B Surface Antigen Seroconversion in Chronic Hepatitis B Virus Infection |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25505294 https://www.proquest.com/docview/1642607952 https://www.proquest.com/docview/1808639797 |
Volume | 194 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEIgXBANGuclI8IAqd4njOM4jK6ByGU-b2J6ixHHWCkimNkEqf4E_jY_tpMnEJuAlquwkbv19PT7HPheEXvhFzIVWo4koMk5YHPgkLryYcJGGIshFwDIIFD78zOfH7MNJeDIa_ep5LTV1NpU__xhX8j-o6jaNK0TJ_gOy3Ut1g_6s8dVXjbC-_jXGPYcMuamrr-DGDicA4PqqFT8FLq4LBX7T9XI9OZism1WRmiiBGhJxTvQXrYzrudk3g-0PafPlDp76sVw1W8-tsq_SboPLbP4JCDixiZ1emuMzr7fZ8KUxrFmmRM_jWUeptWmeV-UZOW22dJ0tlqbjtCGzRdNrtqJy3qgN-dQuvW7nwgcnQWJjN6fKSdtQ267c4wNxbIseO97RnnDltrDoRaHPtJEDQt_9vimYjNymGe9x4Py7IQEFi4y6IYaJttuua-g61TYHlMN48_5jt6xzrc3Yc24YcP_icJBV2r1gqOJcYrcY_eXoDrrtEMKvLYvuopEqd9ENW4p0s4tuHjoni3sIahliRytcFbijFa5K3KMV7giCD7CjFXa0wkNa4WWJHa0GTxla4Y5W99Hxu7dHszlxFTqIDAJakyLIc1_mNKMpA12RZdSTmWSCZaGU1M8jWTChAsZiJcKChkGYh1HhCyEUZYoHD9BOWZXqIcK-SHMa8Uir81Ib7YXI4iDW6xFNY1qIkI3RfjupiXTp66GKyrdEm7GASNIikjhExuhV98S5Td1yxb3PW5wSLV_h0MxOZeJzqOEQxSG94h7hCXNAHo3RngW5G7ElxaNLex6jW9t_xxO0U68a9VRrunX2zDDwNxI0rJ8 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effects+of+cytokines+on+spontaneous+hepatitis+B+surface+antigen+seroconversion+in+chronic+hepatitis+B+virus+infection&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Wu%2C+Jia-Feng&rft.au=Hsu%2C+Hong-Yuan&rft.au=Chiu%2C+Yu-Chun&rft.au=Chen%2C+Huey-Ling&rft.date=2015-01-15&rft.eissn=1550-6606&rft.volume=194&rft.issue=2&rft.spage=690&rft_id=info:doi/10.4049%2Fjimmunol.1401659&rft_id=info%3Apmid%2F25505294&rft.externalDocID=25505294 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon |